Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4635 USD | -3.42% | -8.33% | -67.13% |
Apr. 01 | BTIG Research Downgrades P3 Health Partners to Neutral From Buy | MT |
Mar. 28 | Transcript : P3 Health Partners Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Evolution of the average Target Price on P3 Health Partners Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering P3 Health Partners Inc.
BTIG | |
Lake Street | |
TD Cowen | |
William Blair & Co. |
EPS Revisions
- Stock Market
- Equities
- PIII Stock
- Consensus P3 Health Partners Inc.